"Hematoxylin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dye obtained from the heartwood of logwood (Haematoxylon campechianum Linn., Leguminosae) used as a stain in microscopy and in the manufacture of ink.
| Descriptor ID |
D006416
|
| MeSH Number(s) |
D03.383.663.283.600 D03.633.100.150.600
|
| Concept/Terms |
Hematoxylin- Hematoxylin
- Hemotoxylin
- Hematoxiline
- Hydroxybrasilin
- Hydroxybrazilin
|
Below are MeSH descriptors whose meaning is more general than "Hematoxylin".
Below are MeSH descriptors whose meaning is more specific than "Hematoxylin".
This graph shows the total number of publications written about "Hematoxylin" by people in this website by year, and whether "Hematoxylin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hematoxylin" by people in Profiles.
-
Potential Use of Hematoxylin-curcumin as Natural Bio-stains for Tissue Sections. J Contemp Dent Pract. 2019 Jan 01; 20(1):1-2.
-
'Third Space' Perspective on Redefining Oral Pathology: Hypothetical Considerations. J Contemp Dent Pract. 2018 Nov 01; 19(11):1293-1294.
-
Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer. Mod Pathol. 2017 09; 30(9):1204-1212.
-
Hematoxylin in History-The Heritage of Histology. JAMA Dermatol. 2017 03 01; 153(3):328.
-
Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets. Arch Pathol Lab Med. 2013 Jan; 137(1):32-40.
-
Establishment of platform for screening insulin-like growth factor-1 receptor inhibitors and evaluation of novel inhibitors. Acta Pharmacol Sin. 2011 Jul; 32(7):930-8.
-
Lymphoglandular bodies in malignant tumors: with special reference to histologic specimens. Ann Diagn Pathol. 2008 Aug; 12(4):249-251.